The drug regulatory authority on Thursday approved Reliance Life Sciences, part of India’s largest private sector enterprise-application, seeking to conduct clinical trials of its recombinant protein-based Covid-19 vaccine candidate.
Copyright © 2024 | WordPress Theme by MH Themes